Spec. Dr. Ömer Türker

He graduated from Izmir Science High School and Hacettepe University Faculty of Medicine. 
He completed his residency in 2004 at Ege University, Faculty of Medicine, Department of Nuclear Medicine. 
 He worked at Istanbul Gulhane Medical Academy, Department of Nuclear Medicine in 2005.
He  successfully past the MCQ examination for the European Fellowship in Nuclear Medicine in 2005. 
His first clinical trial on thyroid diseases was published by Journal of Endocrinology in 2006. It became the first registered clinical trial of Turkey. It has been cited for more than 200 times and it has been one of the most read articles for more than 13 years. 
He is writer and/or hoc reviewer of many international journals like Thyroid, Journal of Endocrinology, ...
His articles on thyroid diseases have been cited internationally more than 250 times.
Autoimmune thyroiditis (Hashimoto's thyroiditis), Graves' disease, nodular diseases of thyroid, follow up of well differentiated thyroid cancers, clinical decision for "radioiodine treatments and nuclear medicine applications" are areas of his expertise.
Note: Only polyclinic service (for thyroid patients) is provided until the establishment of the new "nuclear imaging and treatment" center.
Biochemical analysis of FT3, FT4 (thyroid hormones), TSH (thyroid stimulating hormone), Tg (thyroglobulin), TPOAb (thyroid peroxidase antibody), TgAb (thyroglobulin antibody), parathormon, calcium, ESR (erythrocyte sedimentation rate), ...
Diagnostic DOPPLER USG (in the Radiology Department).
Our hospital also has thyroid surgeons and clinical pathologists.
(patient education website: www.hasimato.com) 

1) Selenium treatment in autoimmune thyroiditis: 9-month follow-up with variable doses (more than 200 international citations

Turker O, K. K., K. I., D. I.

J Endocrinol. 2006 Jul;190(1):151-6.

2)Selenium treatment in autoimmune thyroiditis.

Turker O, K. I.

Thyroid. 2006 Dec;16(12):1326.

3) There is immunological benefit of selenium treatment in autoimmune thyroiditis.

Turker O, K. I.

Thyroid. 2008 Jun;18(6):671-2.

4)The clinical role of molecular imaging: positron emission tomography/computed tomography and (90)yttrium-DOTATOC in the management of medullary thyroid cancer.

Turker O, D. I.

Thyroid. 2010 Feb;20(2):233-4.

5) Radioiodine accumulation in a large adnexal cystadenofibroma.

Turker O, D. I., K. K.

Thyroid. 2010 May;20(5):561-2.

6) A "semihot-semicold" but "pure" adenoma.

Turker O, K. I., D. I.

Thyroid. 2008 Jul;18(7):793.